Home » Topics » BioWorld Science

BioWorld Science
RSS

SARS-CoV-2 vaccine shows promise in first peer-reviewed article on a potential COVID-19 vaccine

April 7, 2020

FDA clears IND application for EIDD-2801 for COVID-19

April 7, 2020

FDA accepts IND for phase I testing of INO-4800 for COVID-19

April 7, 2020

Pfizer discloses new CCR6 antagonists

April 7, 2020

Hanmi Science presents new EGFR mutant inhibitors

April 7, 2020

Bristol-Myers Squibb synthesizes new LPA1 receptor antagonists

April 7, 2020

Chinese researchers patent compounds for cancer

April 7, 2020

Ono Pharmaceutical divulges PTGDR2 antagonists

April 7, 2020

Novel alpha-ketoamide inhibitor with activity against main protease of SARS-CoV-2

April 7, 2020

IRF-1 as a novel therapeutic target in CKD

April 7, 2020

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...